Effects of Bifidobacterium on immune and gastrointestinal function - A Randomized, Double-blind, Placebo-controlled, Parallel-group Study
- Conditions
- Healthy adults
- Registration Number
- JPRN-UMIN000042392
- Lead Sponsor
- DeNA Life Science, Inc
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Not provided
1. Subjects who are receiving continuous pharmaceutical treatment 2. Subjects with previous and/or current medical history of serious disease (e.g. liver, kidney, heart, lung, blood) 3. Subjects with prevalence of digestive system comorbidities and previous medical history of the system 4. Subjects with serious anemia 5. Subjects with a risk of presenting allergic reaction to test capsule, other food, and medicine 6. Subjects who are taking medicine, supplement, and/or any food/functional food claiming an effect on immune function related evaluation items 7. Females who are pregnant and/or lactating, or those with willingness/intention to become pregnant during the study 8. Subjects that plan to have irregular life cycle (e.g. midnight shift work, long-term travel) and/or those with extremely irregular dining and sleep habits 9. Subjects with current or past (less than 3 months) experience of participating in other clinical studies (excluding non-invasive observational studies) 10. Subjects who are judged by the principal investigator to be unsuitable as the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method